Jones Mark Evan 4
4 · Goosehead Insurance, Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Jones Mark Evan
DirectorExecutive Chairman10% OwnerOther
Transactions
- Sale
Class A Common Stock
2025-02-28$119.32/sh−12,678$1,512,739→ 42,972 total - Exercise/Conversion
Employee Stock Options (right to buy)
2025-02-28$40.88/sh−40,000$1,635,200→ 194,000 totalExercise: $40.88Exp: 2030-04-01→ Class A Common Stock (40,000 underlying) - Exercise/Conversion
Class A Common Stock
2025-02-28$40.88/sh+40,000$1,635,200→ 78,951 total - Sale
Class A Common Stock
2025-02-28$118.54/sh−23,301$2,762,101→ 55,650 total - Sale
Class A Common Stock
2025-02-28$120.53/sh−2,018$243,230→ 40,954 total - Sale
Class A Common Stock
2025-02-28$121.50/sh−2,003$243,365→ 38,951 total
Footnotes (6)
- [F1]This does not reflect shares directly held by the reporting person's spouse, who is independently a reporting person of the issuer.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.00 to $118.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.00 to $119.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.12 to $121.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F6]One third (1/3rd) of the shares subject to the option, which represents the right to purchase a total of 234,000 shares, vested and became exercisable, subject to continued employment, on each of the second, third, and fourth anniversaries of the grant date, which was April 1, 2020.